Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety ...
BUZZ BOMB™ captures over 400,000 views and a spike in online revenue driven by strategic brand expansion and Ashley ...
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company") today announced that its wholly owned subsidiary ...
What’s Acer got going on over at its US warehouses, I wonder? While other manufacturers are struggling to get laptops under the $800 mark, Acer seems to be sitting on a never-ending supply of refurbs ...
Aspire Biopharma’s new sublingual powder bypasses digestion, delivering alprazolam directly for faster anxiety and panic relief.
ESTERO, FL / ACCESS Newswire / August 18, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today ...
H1 2026: Finalize formulation and manufacture test product. H1 2026 Initial Phase 1 pharmacokinetic clinical cross-over study. "Our pipeline is focused on research in therapeutic areas where we can ...
We looked globally for a partner that understood 'Quality' not just as testing, but as a culture.”— Gowri Shankar ...